There certainly are a lot of options for investors to choose from on the Australian share market.
But three that could be fantastic options right now are listed below. Here's what you need to know about them:
Image source: Getty Images
Adore Beauty Group Limited (ASX: ABY)
The first ASX share to look at is Adore Beauty. Australia's leading online beauty retailer has been growing very strongly during the pandemic. For example, in February the company reported half year revenue of $96.2 million and EBITDA of $5.2 million. This was up 85% and 188%, respectively, over the prior corresponding period. Positively, thanks to the shift online and its growing active customer base, Adore Beauty appears well-placed to continue its positive form over the coming years.
UBS is positive on Adore Beauty. It appears confident its strong market position and growing customer numbers will underpin further strong growth in the future. UBS currently has a buy rating and $6.20 price target on its shares.
Goodman Group (ASX: GMG)
Another ASX share to consider buying is Goodman Group. It is a leading integrated commercial and industrial property group that owns a high quality portfolio of assets. Positively, many of its assets have exposure to structural tailwinds such as ecommerce and the digital economy. As a result, they look likely to be in demand with customers for a long time to come. This should be supportive of strong rental income and distribution growth over the next decade.
Macquarie is a fan of Goodman. This morning the broker retained its outperform rating and $20.39 price target on its shares.
Ramsay Health Care Limited (ASX: RHC)
A third ASX share to consider buying is Ramsay Health Care. It is a leading private healthcare company with operations across the world. After struggling during the height of the pandemic, Ramsay has bounced back strongly in recent months and is now benefiting from a backlog in surgeries. Looking ahead, the company looks well-placed for long term growth thanks to increasing demand for healthcare services due to ageing populations.
Macquarie is also positive on the company. Last month it reaffirmed its outperform rating and $75.00 price target on Ramsay's shares.
